BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21745581)

  • 1. Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI.
    Cantin S; Villien M; Moreaud O; Tropres I; Keignart S; Chipon E; Le Bas JF; Warnking J; Krainik A
    Neuroimage; 2011 Sep; 58(2):579-87. PubMed ID: 21745581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer's disease.
    Richiardi J; Monsch AU; Haas T; Barkhof F; Van de Ville D; Radü EW; Kressig RW; Haller S
    Neurobiol Aging; 2015 Jan; 36(1):33-41. PubMed ID: 25146454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
    Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
    J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive reserve modulates task-induced activations and deactivations in healthy elders, amnestic mild cognitive impairment and mild Alzheimer's disease.
    Bosch B; Bartrés-Faz D; Rami L; Arenaza-Urquijo EM; Fernández-Espejo D; Junqué C; Solé-Padullés C; Sánchez-Valle R; Bargalló N; Falcón C; Molinuevo JL
    Cortex; 2010 Apr; 46(4):451-61. PubMed ID: 19560134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Dinov ID; Dutton RA; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Brain; 2006 Nov; 129(Pt 11):2867-73. PubMed ID: 17018552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients.
    Wirth M; Pichet Binette A; Brunecker P; Köbe T; Witte AV; Flöel A
    J Cereb Blood Flow Metab; 2017 Mar; 37(3):814-824. PubMed ID: 27037094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa does not change cerebral vasoreactivity in Parkinson's disease.
    Krainik A; Maillet A; Fleury V; Sahin M; Troprès I; Lamalle L; Thobois S; Fraix V; Villien M; Warnking J; Pollak P; Pinto S; Krack P
    Mov Disord; 2013 Apr; 28(4):469-75. PubMed ID: 23238963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in cerebral blood flow and vasoreactivity to CO2 measured by arterial spin labeling after 6days at 4350m.
    Villien M; Bouzat P; Rupp T; Robach P; Lamalle L; Troprès I; Estève F; Krainik A; Lévy P; Warnking JM; Verges S
    Neuroimage; 2013 May; 72():272-9. PubMed ID: 23384523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered amplitude of low-frequency fluctuations in early and late mild cognitive impairment and Alzheimer's disease.
    Liang P; Xiang J; Liang H; Qi Z; Li K; Alzheimer's Disease NeuroImaging Initiative
    Curr Alzheimer Res; 2014 May; 11(4):389-98. PubMed ID: 24720892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.
    Joko T; Washizuka S; Sasayama D; Inuzuka S; Ogihara T; Yasaki T; Hagiwara T; Sugiyama N; Takahashi T; Kaneko T; Hanihara T; Amano N
    Psychogeriatrics; 2016 Nov; 16(6):355-361. PubMed ID: 26756596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
    Janik R; Thomason LA; Chaudhary S; Dorr A; Scouten A; Schwindt G; Masellis M; Stanisz GJ; Black SE; Stefanovic B
    Biochim Biophys Acta; 2016 May; 1862(5):957-65. PubMed ID: 26521151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of visually evoked BOLD responses during carbogen inhalation: implications for calibrated MRI.
    Gauthier CJ; Madjar C; Tancredi FB; Stefanovic B; Hoge RD
    Neuroimage; 2011 Jan; 54(2):1001-11. PubMed ID: 20887792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of MRI hippocampal volumetry and arterial spin labeling MR perfusion at 3-Tesla improves the efficacy in discriminating Alzheimer's disease from cognitively normal elderly adults.
    Mak HK; Qian W; Ng KS; Chan Q; Song YQ; Chu LW; Yau KK
    J Alzheimers Dis; 2014; 41(3):749-58. PubMed ID: 24670395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.
    Al-Bachari S; Parkes LM; Vidyasagar R; Hanby MF; Tharaken V; Leroi I; Emsley HC
    Neuroimage Clin; 2014; 6():1-8. PubMed ID: 25379411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in Patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI.
    Mandell DM; Han JS; Poublanc J; Crawley AP; Stainsby JA; Fisher JA; Mikulis DJ
    Stroke; 2008 Jul; 39(7):2021-8. PubMed ID: 18451352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study.
    Bangen KJ; Restom K; Liu TT; Wierenga CE; Jak AJ; Salmon DP; Bondi MW
    J Alzheimers Dis; 2012; 31 Suppl 3(0):S59-74. PubMed ID: 22531427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study.
    Rémy F; Mirrashed F; Campbell B; Richter W
    Neuroimage; 2005 Mar; 25(1):253-66. PubMed ID: 15734360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.